SCHEMBL3421025

SCHEMBL3421025

C[C]1O[C@@H]1CC=C(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8749379 0.72 PRKCA (0.46)
SCHEMBL5864513 0.62
SCHEMBL30773540 0.62
SCHEMBL11221232 0.60 LSS (0.40)
SCHEMBL8187222 0.60 LSS (0.40)
SCHEMBL5084457 0.60 LMNA (0.33)
SCHEMBL1697969 0.60
SCHEMBL2439872 0.56
SCHEMBL5075179 0.56
SCHEMBL27832626 0.56 ALOX5 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8399512-B2 Biocompatible biodegradable fumagillin analog conjugates MERSANA THERAPEUTICS, INC. (US) 2013-03-19 US claimed
EP-2217283-A2 BIOCOMPATIBLE BIODEGRADABLE FUMAGILLIN ANALOG CONJUGATES Mersana Therapeutics, Inc. (US) 2010-08-18 EP claimed
US-20090148396-A1 BIOCOMPATIBLE BIODEGRADABLE FUMAGILLIN ANALOG CONJUGATES MERSANA THERAPEUTICS, INC. (US) 2009-06-11 US claimed
WO-2009073445-A2 BIOCOMPATIBLE BIODEGRADABLE FUMAGILLIN ANALOG CONJUGATES MERSANA THERAPEUTICS, INC. (US) 2009-06-11 WO claimed